SIRT1 and breast carcinoma: In breast cancer patients, decrease of SIRT1 was associated with reduced PRRX1 but increased KLF4 (Figure S11D), and the latter was positively correlated with distal metastases (P<0.001, χ2 test) (Fig. 7i).